Clinical Trial Update: Adjunctive iTBS for First-Episode Schizophrenia [NA]

View source ↗

Summary

The clinical trial evaluating adjunctive intermittent theta-burst stimulation for first-episode schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Intermittent theta-burst stimulation (iTBS) adjunctive therapy

Snippet

Sponsor: The First Hospital of Hebei Medical University | Conditions: Schizophrenia Disorder | NA | Status: COMPLETED